Msx and Dlx homeoproteins control the morphogenesis and organization of craniofacial skeletal structures, specifically those derived from the pharyngeal arches. In vitro Msx and Dlx proteins have opposing transcriptional properties and form heterodimeric complexes via their homeodomain with reciprocal functional repression. In this report we examine the skeletal phenotype of Msx1; Dlx5 double knock-out (DKO) mice in relationship with their expression territories during craniofacial development. Co-expression of Dlx5 and Msx1 is only observed in embryonic tissues in which these genes have independent functions, and thus direct protein interactions are unlikely to control morphogenesis of the cranium. The DKO craniofacial phenotypes indicate a complex interplay between these genes, acting independently (mandible and middle ear), synergistically (deposition of bone tissue) or converging on the same morphogenetic process (palate growth and closure). In the latter case, the absence of Dlx5 rescues in part the Msx1-dependent defects in palate growth and elevation. At the basis of this effect, our data implicate the Bmp (Bmp7, Bmp4)/Bmp antagonist (Follistatin) signal: in the Dlx5 K/K palate changes in the expression level of Bmp7 and Follistatin counteract the reduced Bmp4 expression. These results highlight the importance of precise spatial and temporal regulation of the Bmp/Bmp antagonist system during palate closure. q
Introduction
The mammalian face develops from the coordinated growth, morphogenesis and fusion of several embryonic primordia: the frontonasal processes, two maxillary and two mandibular prominences, located around the primitive mouth. The maxillary and mandibular prominences derive from the first pharyngeal arch whose mesenchyme is colonized predominantly by neural crest-derived skeletogenic cells. Ventrally to the mouth, the mandibular arches fuse in the midline and give rise to the skeletal elements of the mandible. Dorsally to the mouth, the maxillary prominences grow and fuse anteriorly with the frontonasal processes, giving rise to the upper lip and the primary palate. The secondary palate develops bilaterally as two shelves that grow from the internal surface of the maxillae and first project vertically along the sides of the tongue (E12-E13). The shelves then elevate and become oriented horizontally, eventually they fuse with each other, with the base of the nasal septum and with the primary palate (E14-E15) (Ferguson, 1998) .
The comprehension of the genetic regulation at the basis of craniofacial patterning and morphogenesis is a formidable task and is being achieved mainly by the analysis of developmental phenotypes in mutant mouse strains (Wilkie and Morris-Kay, 2001; Francis-West et al., 2003; Couburne and Sharpe, 2003; Richman and Lee, 2003; Thyagarajan et al., 2003; Murray and Schutte, 2004) . Among the many gene families that have been implicated, the closely related Dlx and Msx homeobox transcription factors gene play a central role (Davidson, 1995; Depew et al., 1999; 2002; Merlo et al., 2000; Bendall and Abate-Shen, 2000; Beverdam et al., 2002; Panganiban and Rubenstein, 2002) . Msx1 and Msx2 are widely expressed at many embryonic sites, in particular those where epithelial-mesenchyme interactions take place (Davidson, 1995; Bendall and Abate-Shen, 2000) . During early head development, Msx1 and Msx2 are expressed in migrating neural crest cells, which populate the distal regions of the arches and the frontonasal processes (Bendall and Abate-Shen, 2000; Alappat et al., 2003 and references therein) . Similarly, Dlx genes are expressed in a proximal-distal combinatorial pattern in the pharyngeal arches (Depew et al., 2002; Merlo et al., 2003) . Differential expression of Dlx genes in the arches suggest that they confer positional identity on the skeletogenic cells, this notion being supported by the analysis of craniofacial phenotypes in single and double knock-out (DKO) mice (Beverdam et al., 2002; Depew et al., 2002) . At later embryonic stages, the partially overlapping expression of the various members of the Dlx and Msx gene families is thought to mediate epithelial-mesenchymal interactions leading to correct induction, growth and morphogenesis of embryonic structures such as the teeth, the palate, the mandible (Bendall and Abate-Shen, 2000 and references therein).
In the Msx1 K/K mice severe craniofacial defects are observed, including palatal cleft, due to failure of the shelves to elevate and fuse, mandible and middle ear ossicle deformity, absence of molars and delayed ossification (Satokata and Maas, 1994) . All these defects have been associated to the expression of Msx1 in the corresponding embryonic territories. In the Dlx5 null mice, similar skeletal structures are affected, including the palate, the mandible, the middle ear ossicles; these mice exhibit also a generalized delay in the ossification process in the calvaria (Acampora et al., 1999; Depew et al., 1999; Merlo et al., 2000; . The similarity of the skeletal elements affected by Msx1 or Dlx5 mutation prompted us to investigate a possible interplay between these genes.
In vitro, the Msx and Dlx proteins appear to have opposing transcription properties with Msx functioning as repressors and Dlx as activators (Alappat et al., 2003; Panganiban and Rubenstein, 2002) . In vitro, Msx1, Dlx2 and Dlx5 recombinant proteins form heterodimers via their homeodomain and, by doing so, they reciprocally inhibit their activities (Zhang et al., 1997) . Should this observation hold true in vivo, some of the phenotypes observed in Msx1 K/K mice may be due to altered Dlx5 activity, and viceversa. In this case, one might expect that in Msx1; Dlx5 DKO mice some of the defects be aggravated or rescued. The essential condition for this regulation to occur is that the two genes be expressed in the same cells at the same time, as proposed by Zhang and coworkers (1997) . In this study, we first examined the expression pattern of Msx1 and Dlx5 in the craniofacial primordium. Next, we generated Msx1; Dlx5 DKO mice and examined their phenotype compared to those of single mutants. In most structures, the two genes are expressed in separate territories and seem to act independently. On the contrary, the absence of Dlx5 partially rescues the palatal defects of Msx1 null mice, although there is no co-expression. We analyzed the signals possibly involved in this regulation and provide data that implicate the Bmp/Bmpantagonist signal in the process genetically controlled by Dlx5 and Msx1 in palate formation.
Results

Frequency of Msx1-Dlx5 DKO mice
Msx1
nlacZ mice were crossbred with Dlx5 lacZ mice, double heterozygous males and females were obtained at the expected frequency. Crossbreeding of double heterozygotes yielded Msx1 K/K ; Dlx5 K/K embryos and pups at a frequency lower than expected (5/98, 5.1 vs. 6.25%, not statistically significant). All delivered DKO, as well as single Msx1 K/K and Dlx5
animals, died soon after delivery.
Expression of Dlx5 and Msx1 in craniofacial structures
At the E10.5 stage of development, Msx1 and Dlx5 are coexpressed in the distal mandibular arch (Bendall and Abate-Shen, 2000, Fig. 3) . We have compared expression of Msx1 and Dlx5 at later stages by X-gal staining of serial sections of Msx1 nlacZ and Dlx5 lacZ heterozygous (normal) embryos at E13.5 and E14.5 (Figs. 1, 6 ). In situ hybridization on relevant sections was used to confirm the endogenous expression.
In the anterior palate region, marked by the vomeronasal organs (VNO), Msx1, but not Dlx5, is expressed in the mesenchyme, in the chondrogenic tissue surrounding the VNO and in a wide region of the maxilla mesenchyme (Fig. 1B,D) . Dlx5, but not Msx1, is expressed in the VNO and the olfactory epithelium (Fig. 1A,C) . Co-expression of Msx1 and Dlx5 is limited to the most lateral region of the maxillary mesenchyme (Fig. 1A,B) . In the posterior palate region, marked by the molar tooth buds, neither Msx1 not Dlx5 are expressed. Instead, co-expression of Msx1 and Dlx5 is found in the maxilla mesenchyme corresponding to osteogenic areas (Fig. 1C,D) . Msx1 is also strongly expressed in the molar tooth papillae, while Dlx5 is expressed in the osteogenic mesenchyme surrounding the tooth (Figs. 1, 6 ) and in the enamel knot cells. Neither Msx1 nor Dlx5 are expressed in the dental epithelium (Bendall and Abate-Shen, 2000; Alappat et al., 2003; Merlo et al., 2003) . In summary Msx1 is expressed in the anterior, but not in the posterior, palate (see also Zhang et al., 2002; Nugent and Green, 1998; Givens et al., 2005) while Dlx5 is not expressed in either the anterior or the posterior palate. We then examined the distribution of lacZ expressing cells in the palate, comparing Msx1 and Dlx5 heterozygous embryos with the corresponding homozygous ones (Fig. 1E-H) . lacZ expression is maintained in the correct position in both the Msx1 K/K and Dlx5 K/K . Thus, it is unlikely that the palatal phenotypes observed in these mutant mice and the rescue observed in the DKO head be caused by a missing cell population.
The palatal phenotype
In the Msx1 null mice the palatal shelves fail to elevate from a vertical to an horizontal position; consequently they do not fuse and remain opened, with the base of the nasal septum is exposed in the oral cavity (Figs. 1H, 2A ,G,H) (Satokata and Maas, 1994; Houlzestein et al., 1997) . In the Dlx5 null mice, the palatal shelves are partially formed and elevated but fail to complete growth and to fuse in the midline (Fig. 2E,F ) (Acampora et al., 1999; Depew et al., 1999) . While the Msx1 phenotype is fully penetrant, the Dlx5 one shown in Fig. 2 is the most common of a range of phenotypes; in the more severe (rare) form a near complete opening of the palatal shelves is observed, while in the mildest form (also rare) the shelves grow and elevate to come into contact, however, they fail to fuse. In DKO E13.5 embryos (2/2) the shelves are partly formed and elevated (Fig. 2B ), but do not come to contact and fuse. At P0 the shelves are present, elevated, and partially ossified (3/3), although fail to fuse in the midline. This leads to the condition of a mild clefting (Fig. 2J ,K) similar to that observed in Dlx5 null mice. This observation indicates that the severe Msx1-related palatal phenotype can be partially rescued in the DKO head.
We set forth to investigate the molecular regulation at the basis Dlx5-dependent rescue of the Msx1 palate phenotype. In Msx1 K/K embryos a reduced expression of Shh, Bmp4 and Bmp2 in the medial edge epithelium (MEE) and mesenchyme of the anterior region has been reported (Zhang et al., 2002) . The restoration of Bmp4 expression in the palate of Msx1 K/K mice could partially rescue the growth and elevation of the shelves (Zhang et al., 2002) . It seemed therefore likely that the loss of Dlx5 might infringe on the Bmp expression and/or regulation. Since Dlx5 is not expressed in the Bmp2-4 territory, such putative function of Dlx5 should be non-cell-autonomous, and might reasonably include the secreted Bmp antagonist Noggin, Chordin, Follistatin. Alternatively, Msx1 might repress Dlx5 transcription, and Dlx5, in turn, might normally inhibit cell proliferation of the palatal mesenchyme. We tested both of these hypotheses.
Expression of Dlx5 and Dlx6 is not altered in Msx1
K/K mice Expression of Dlx5 and Msx1 in the developing head appears to be complementary (Fig. 1 ). For this reason, the possibility that the Msx1 protein may normally repress Dlx5 expression in the palate appeared likely. We have examined expression of Dlx5 in E11 Msx1 K/K embryos by whole-mount in situ hybridization. As shown in Fig. 3A -D, expression of Dlx5 was detected both in the WT and in the Msx1 K/K embryos in the expected territories (1st and 2nd pharyngeal arches, ventral cephalic epithelium, olfactory and otic epithelium) with no appreciable difference. These results indicate that Dlx5 is not under transcription control of Msx1. We also examined expression of Msx1 (Fig. 3E , F) and Msx2 (not shown) in the pharyngeal arches of E10.5Dlx5
embryos. In both WT and mutant embryos Msx1 is expressed in the expected territories (distal mandibular arch, maxillary arch, mesenchyme of the frontonasal processes, limbs) with no significant difference.
Msx1 could inhibit Dlx5 expression at a later stage of palate formation. We have therefore examined Dlx5 expression in sections of E14.5 normal and Msx1 K/K heads by in situ hybridization. As shown in Fig. 3G , H, expression of Dlx5 in the anterior palate is undetectable in both the WT and the Msx1 K/K palate. Instead, in the posterior palate, Dlx5 expression is slightly expanded toward the midline in the Msx1 K/K palate ( Fig. 3J, K ). This region, however, does not overlap with either the Msx1 or Bmp4 expression territories (Zhang et al., 2002) . Finally, Dlx5 expression is observed in the lateral maxillary mesenchyme equally in the normal and in the Msx1 K/K head, and is unchanged in all other embryonic territories. These results suggest that Dlx5 expression in vivo is largely independent of Msx1.
Expression of Bmps and Bmp antagonists in Msx1 and Dlx5 mutant embryos
Dlx5 could directly act as an inhibitor of Bmp4 expression, or could modulate Bmp function by regulating the expression of Bmp antagonists, such as Noggin, Chordin, or Follistatin. Bmp4 is expressed at sites of fusion between prominences of the head primordium, including the palate (Gong and Guo, 2003) . In E13-E14 embryos Bmp4 is expressed in a restricted domain of the anterior palate mesenchyme, adjacent to the MEE (Fig. 4A,D) . Importantly, several genes coding for morphogenetic molecules, including Bmp2, Bmp4, Bmp7, Follistatin, Shh and FGFs, are expressed in this location. This domain can be considered a signaling center for palate growth. In the Msx1 K/K palate at E13.5 and E14.5 Bmp4 
and DKO (J,K) mice, at P0. The picture on the right is a higher magnification of the one on the left, detailing the palatal region. The presphenoid bone (Pr) and the palatal shelves (black arrows) are indicated, the absence of the palatal shelves in the Msx1 K/K head (H) is indicated with asterisks. A drawing of the palatal shelves is shown on the right, for clarity. expression in the anterior region is markedly reduced, however not absent (Zhang et al., 2002; Fig. 4C) . Likewise, Bmp4 expression is reduced in the Dlx5 K/K palate ( Fig. 4B ,E) and is nearly absent in the DKO (Fig. 4E' ). To control for tissue preservation and hybridization specificity, the Bmp4 signal on the incisor tooth dental papillae in the same sections were compared and found to be equal (insets in Fig. 4D,E) .
We then examined the expression of Bmp7 in the palate of Dlx5 K/K , Msx1 K/K and DKO embryos at E13.5 and E14.5. At E13.5 Bmp7 is normally expressed in the signaling center of the anterior palate in both the epithelium and the underlying mesenchyme (Fig. 4J,L) . Bmp7 expression extends along the anterior-posterior length of the shelves (Fig. 4F-H) , where it is found in the palatal epithelium, but not in the mesenchyme (Fig. 4N,P) . Whole-mount in situ hybridization on WT, Dlx5 K/K and Msx1 K/K heads showed a similar level of Bmp7 expression ( Fig. 4F-H) ; however hybridization on Dlx5
palates shows an increase in Bmp7 signal both anteriorly ( Fig. 4K ) and posteriorly (data not shown). In the Msx1
palate Bmp7 expression is decreased anteriorly, but increased posteriorly. Finally, Bmp7 expression was found to be increased in the DKO palate (Fig. 4K') . To control for tissue preservation and specificity of the hybridization, the Bmp7 signal on the eye lids in the same sections were compared (insets in Fig. 4J ,K,M) and the results are summarized in Fig. 7 . To confirm the previous finding, Bmp7 mRNA level in WT, Msx1 K/K and Dlx5 K/K palatal shelves was quantified by RealTime PCR (Fig. 4N) . A 1.5 and a 1.6 fold increase in the Bmp7 template was observed, respectively, in the Msx1 K/K and in the Dlx5 K/K RNA sample, in two experiments (with biological replicates). The increased Bmp7 expression cannot be attributed to a direct Dlx5 regulation, and therefore a noncell-autonomous effect is the most likely mechanism.
Expression of the Bmp-antagonist molecules, Noggin, Chordin, and Follistatin was examined in E13.5 and E14.5 Dlx5 mutant heads. At E13.5 Follistatin expression is normally restricted to a dorsal (nasal) domain of the anterior palate epithelium; in Dlx5 K/K palates this expression domain is unchanged (Fig. 5A,B ). In the Msx1 K/K palate, expression in this region was reduced and irregularly distributed (Fig. 5C ). Posteriorly, Follistatin is expressed in the palatal epithelium, with higher expression on the tip and on the ventral (oral) domain (Fig. 5E ). In the Dlx5 K/K palate Follistatin expression in the mid-posterior region was reduced and irregularly distributed (Fig. 5F ). In the posterior palate of Msx1
embryos Follistatin expression is detected at levels similar to the WT (Fig. 5G) . In DKO embryos, Follistatin expression is reduced both anteriorly and posteriorly (Fig. 5D,H) . To control for tissue preservation and hybridization specificity, Follistatin , and with Msx1 probe on Dlx5 K/K E11embryos (E,F). A,B,E,F, lateral view; C,D, frontal view. Msx1 and Dlx5 signal on the 1st arch is indicated (black arrows). Msx1 hybridization is also observed on the maxillary arch and the frontonasal process. Dlx5 signal is also observed on the 2nd arch, the olfactory placodes, the otic vesicle. (Bottom) Hybridization with Dlx5 probe on frontal sections of the anterior (G,H) and posterior (J,K) palate of E14.5 Msx1 K/K embryos. Expression is observed in a lateral domain, corresponding to the maxilla. In the Msx1 K/K head the Dlx5 territory is slightly expanded towards the midline (sketched with a dotted red line). Abbreviations: FNP, frontonasal process; Mx, maxillary arch; OP, olfactory placodes; OV, otic vescicle; Se, septum (nasal); 2nd, second (hyoid) arch; other abbreviations as in previous figures. signal on the dental epithelium of the molar tooth buds in the same sections were compared (insets in Fig. 5E,H) . These results are summarized in Fig. 7 .
Noggin is expressed in chondrogenic condensations, in the olfactory and VN epithelium, and in a restricted region of the maxilla mesenchyme, but not in the palate proper (Fig. 5J) . Examination of serial sections of a WT embryo hybridized with Dlx5 or Noggin indicates that expression of these two genes in the maxillary region only partially overlaps (Fig. 5 , compare J and L, red arrows) and furthermore Noggin expression did not significantly change in Dlx5 K/K heads (Fig. 5K) . To control tissue preservation and specificity of hybridization, Noggin signal on the ventricular zone of the forebrain were compared (insets in Fig. 5J,K) . For Dlx5, control hybridization on the ganglionic eminence of the forebrain is shown (inset in Fig. 5L ). Finally, Chordin expression in WT and Dlx5 K/K palate was examined and found not to change significantly (data not shown). As further control for the relative position of the head territories and the specificity of the observed differences, we examined expression of the morphogens Wnt5a and Wnt5b. In E14.5 embryos, Wnt5a is expressed in the medial mesenchyme of both the anterior and the posterior palate (Fig. 5M) . In Dlx5 K/K palatal shelves Wnt5a expression is maintained in the corresponding territory (Fig. 5N) . Wnt5b is expressed in a territory partly overlapping with Noggin and Dlx5 (Fig. 5P) . In Dlx5 K/K heads Wnt5b expression in this domain is reduced (Fig. 5Q) suggesting a generalized dysfunction of the Dlx5 expressing cells in this region.
The mandible and middle ear phenotypes
In the developing jaw Msx1 nlacZ is expressed at E14.5 in a large mesenchymal domain including the dental papilla, but not in the dental epithelium (Fig. 6B,B' ). In equivalent sections Dlx5 lacZ is expressed in osteogenic areas around the incisor teeth buds (Fig. 6A,A' ) and the Meckel's cartilage (data not shown), but not in the dental epithelium and papilla. Thus expression of Dlx5 and Msx1 overlaps only in discrete regions of osteogenic mesenchyme. The jaws of WT, Dlx5
K/K and DKO mice, as well as the combined genotypes at P0, were compared ( Fig. 6C-H) . While both the Dlx5 K/K (Fig. 6D ) and the Msx1 K/K (Fig. 6F ) jaws showed the expected defects (Acampora et al., 1999; Depew et al., 1999; Satokata and Maas, 1994) , in the DKO jaw both the coronoid process and the molar teeth are missing (Fig. 6H) ; these defects are related, respectively, to the Dlx5 and the Msx1 null phenotypes. Furthermore the DKO jaw is shorter and coarser compared to the WT or to the Msx1 K/K , although not as short as the Dlx5 K/K ones. This could be a reflection of the variability of the Dlx5 K/K phenotype (reported in Acampora et al., 1999; Depew et al., 1999) .
In the middle and inner ear region of E14.5 embryos Dlx5 lacZ is expressed in the malleus and incus (Fig. 6J) , while Msx1 nlacZ is expressed in the malleus and the cochlea (Fig. 6K ). In DKO mice at P0 the malleus lacks the head and is deformed, an Msx1-related phenotype and, conversely, an ectopic bone is present, a Dlx5 related phenotype ( Fig. 6M-P) . Thus, in the middle ear region both the Msx1-and the Dlx5-related defects can be recognized in the DKO.
Since, no novel defects or aggravations of known ones is observed in the jaw and middle ear of DKO mice, Msx1 and Dlx5 appear to have independent, non-overlapping functions in these structures.
Other craniofacial phenotypes
In the DKO mice we observe a number of defects related to those observed in the Dlx5 K/K cranium (Table 1 summarized in Table 1 ). No evident aggravation or rescue of these phenotypes has been observed in the DKO, with the exception of the vault bones which appear smaller, heavily perforated and with irregular borders, the fontanels appear rather open on the midline (see Supplementary material, Fig. S1 ). Msx1, but not Dlx5, is expressed in the osteogenic calvaria mesenchyme of the head in E14 embryos. Expression of Dlx5 in this tissue appears at a later stage (E16) (Acampora et al., 1999; Holleville et al., 2003 , and data not shown). Interestingly, both the Msx1 and Dlx5 null mice show a delayed deposition of mineralized tissue in their calvaria (Ryoo et al., 1997; Newberry et al., 1998; Oreste-Cardoso et al., 2002; Acampora et al., 1999; Satokata and Maas, 1994) . This result might indicate a cooperating function of these genes in osteoblast differentiation. A delayed ossification of the fore-and hind-limbs is also observed in the DKO mice (data not shown).
Discussion
We report on the craniofacial phenotype of Msx1;Dlx5 DKO mice, compared with the defects in single Msx1 or Dlx5 mutants. Based on the specific defect and on their expression pattern, we recognize these categories (see also (A) Non-overlapping defects affecting the same skeletal element, indicating that Dlx5 and Msx1 have independent functions (mandible and middle ear). (B) Dlx5-related defects, with no aggravation (ectopic bone, deformed pterigoids, basisphenoid and basioccipital, disorganized foramina of the ala temporalis, hypoplasia and asymmetry of the nasal and otic capsules). (C) Msx1-related defects, with no aggravation (absence of molar teeth and alveolar bone, deformation of the squamosal). (D) Phenotypic rescue (growth, elevation and ossification of the palate). Since Msx1 and Dlx5 are not co-expressed, this effect is non-cell-autonomous. (E) Aggravation of defects affecting elements where genes are co-expressed, indicating a synergistic function (deposition of the calcified bone tissue in the calvaria and phalanges).
Since, the Dlx and Msx homeoproteins are known to form heterodimers in vitro and the interaction leads to abrogation of their DNA-binding and transcriptional activities (Zhang et al., 1997) , some of the phenotypes observed in Msx1 or in Dlx5 mutant animals could be due to altered activity of the cognate protein partner, provided that these genes are co-expressed. With the possible exception of the bone tissue, our data indicate that in vivo functional interactions between Msx1 and Dlx5 are unlikely to occur. The reason for this is two folds: first, their expression territories in the embryonic head at E13-E14 are to a large extent not overlapping; second, in the region of co-expression these two genes carry out independent morphogenetic functions, as demonstrated by the additive feature of the jaw and middle ear phenotypes in DKO mice. The expression of Msx2 is highly overlapping with that of Msx1, while Msx3 is only expressed in the dorsal neural tube (Alappat et al., 2003) ; therefore, functional interaction of Dlx5 with any of the Msx homeoproteins in vivo is improbable.
Alternatively, a repressor activity of Msx1 on Dlx5 expression was taken into consideration. Msx proteins are mainly transcriptional repressors (Alappat et al., 2003) , while Dlx proteins are usually activators (Panganiban and Rubenstein, 2002) . If this hypothesis was true, Dlx5 expression should be augmented or expanded in Msx1 K/K mice. However, we did not observe changes in Dlx5 expression in the absence of Msx1 and thus this possibility has been ruled out.
Dlx and Msx genes in craniofacial and palate development
A variety of molecules have been implicated in signaling during morphogenesis of facial primordia, including secreted molecules (Shh, Bmp, Wnt, Fgf) and transcription factors (Dlx, Otx, Msx, Gli and Tbx) (Wilkie and Morriss-Kay, 2001; Francis-West et al., 2003; Richman and Lee, 2003) . Towards the understanding of how these molecules interact, one of the most informative approaches is the observations of skeletal phenotypes in mice with targeted mutations (Thyagarajan et al., 2003) . Failure of the palatal shelves to grow, elevate or fuse on the midline is the basis of oro-facial cleft, or palatal cleft, the most frequent craniofacial malformation in babies (Ferguson, 1998) . Cleft palate results from the disturbance of tightly controlled events that are regulated by a number of molecules (Houdayer and Bahuau, 1998; Marazita and Mooney, 2004; Johnston and Bronsky, 1995; Prescott et al., 2001; Murray and Schutte, 2004; Kaartinen et al., 1995; Matzuk et al., 1995; Proetzel et al., 1995; Peters et al., 1998; Miettinen et al., 1999; Szeto et al., 1999; Zhao et al., 1999) . Mutation or disruption of the MSX1/Msx1 genes causes in both human and mice oro-facial cleft and tooth agenesis (Satokata and Maas, 1994; Vastardis et al., 1996; Houzelstein et al., 1997; van den Boogaard et al., 2000) . In the mouse palatal cleft is associated with a downregulation of Bmp4 in the anterior palate (discussed below). Disruption of Dlx genes also causes palatal cleft (Acampora et al., 1999; Depew et al., 1999; Qiu et al., 1997) , although they are not expressed in the palatal mesenchyme. Disruption of Dlx5 leads to a less severe cleft, as compared to Msx1: the shelves are usually present and elevated, however, fail to grow properly and to fuse on the midline. Three mechanisms can be proposed: either Dlx genes instruct cells precursor of the palatal anlage early in development (i.e. neural crest or arch ectomesenchyme, where they are expressed), or they control expression of secreted diffusable molecules, or the cleft is the consequence of a generalized deformation of the cranium. With respect to this last possibility, recent data indicate that apoptosis of MEE cells, essential for fusion of the shelves, is sensitive to the distance between the shelves (Gurley et al., 2004) . It is conceivable that palate closure requires a threshold of physical inter-shelf distance not to be exceeded, a distance that can vary as a consequence of dysmorphologies of the cranium. This could partly explain the Dlx5 K/K palatal cleft, in fact its severity correlates with the general severity of other craniofacial defects (unpublished). However, the palatal shelves of the DKO appear more normal than those of either of the single mutants, in spite of the generalized distortion, and therefore, the palatal rescue is not directly related to other craniofacial abnormalities.
The craniofacial phenotypes of Msx and Dlx mutant mice could be interpreted according to two (non-mutually exclusive) models: one in which Msx and Dlx confer spatial identity to the ectomesenchymal cells in a cell-autonomous way, the second in which they mediate non-cell-autonomous instructive signals converging on the regulation of specific signaling centers. In this study, we provide evidence for a non-cellautonomous cooperation between Dlx5 and Msx1 during palate growth, elevation and ossification: these genes are expressed in adjacent domains, with Msx1 but not Dlx5 present in the palate proper. During organ development, interactions between neighboring tissue layers are crucial for growth, morphogenesis and differentiation (Richman and Tickle, 1992; Thesleff et al., 1995) . Palatogenesis as well critically requires interactions between the crest-derived mesenchyme and the overlying epithelium (Slavkin, 1984; Ferguson and Honig, 1984) . Recently, a restricted region of the anterior palate is coming to attention as a signaling center. This region expresses a several morphogenetic molecules including Shh, Bmp, Wnt, Msx1, but not Dlx5 or Dlx6 (unpublished data). Zhang and coworkers (2002) have shown that cell proliferation is reduced in the anterior palatal mesenchyme of Msx1 K/K mice, (see also mice Hu et al., 2001) , K/K (K) embryonic heads at E13.5, compared to expression of Dlx5 in adjacent sections of the WT specimen (L). Red arrows indicate Noggin signal in the maxillary mesenchyme that overlaps with Dlx5. Control hybridizations from the same experiment (ganglionic eminence of the forebrain) are shown for both probes in the lower-right insets. Expression of Wnt5a (M,N) and Wnt5b (P,Q) in WT (M,P) and Dlx5 K/K (N,Q) embryonic heads at E14.5. Expression of Wnt5a is observed in the palatal mesenchyme (black arrows in M) and is unchanged in the Dlx5 K/K specimen (N). Expression of Wnt5b in observed in a mesenchymal domain, lateral to the palatal shelves (sketched in P); In the Dlx5 K/K expression is reduced (red arrow in Q). The section and viewing planes are the same as in Fig. 4 . Abbreviations as in previous figures.
associated with a downregulation of Bmp4, Bmp2 and Shh. Importantly, exogenous expression of Bmp4 in the same region could restore normal cell proliferation, Shh and Bmp2 expression, and palatal elevation. These results clearly indicate that Msx1 controls a genetic hierarchy that entails transcription activation of Bmp4 in a limited co-expression territory, and this in turn controls expression of Shh and Bmp2. ' ) and Msx1 nlacZ (B,B') heterozygous embryos at E14.5. The section planes are clarified in the drawing on the right. Expression of Dlx5 is found in the osteogenic mesenchyme (OM) around the incisor teeth (A'), but not in the dental papilla (DP) (double arrow in A'). Expression of Msx1 is found in the anterior mesenchyme (B), in the OM of the jaw and in the dental papilla (DP) of the incisor teeth (double arrow in B'). Neither Dlx5 nor Msx1 are expressed in the dental epithelium (DE). The clarify the expression territories in A' and B', the position of OM, DE and DP in the developing incisor tooth is sketched on the right. (C-H) Dissected mandible at P0. The normal jaw is shown in C, the DKO is shown in H. Black arrowheads, coronoid process; red arrowheads, molar tooth; asterisks indicate missing structures. (Bottom) the middle ear. (J,K) Expression of Dlx5 lacZ (J) and Msx1 nlacZ (K) in E14.5 heterozygous embryos. (L-P) Skeletal structures of the middle ear at P0. Black arrows indicate the head of the malleus; yellow asterisks (M,P) indicate the ectopic bone. Note that in L-N the styloid process has been dissected out, and that due to distortions of the cranium, the samples M and P are slightly rotated to allow visualization of the Malleus. Abbreviations: Co, cochlea; DE, dental epithelium; DP, dental papilla; In, incus; Ma, malleus; MC, Meckel's cartilage; Md, mandible; OM, osteogenic mesenchyme; Sty, styloid process; T, tongue; TR, tympanic ring. Scale bar in CZ1 mm. Values reported in C-H (on the right) indicate the length of the jaw, in mm.
In this work we establish that Dlx5 inactivation partly rescues the Msx1-dependent defect via increased Bmp7 and reduced Follistatin expression. This observation links Msx1 and Dlx5 in the regulation of a common signaling system critical for palate morphogenesis, as a result of cell nonautonomous interactions between adjacent cells and tissues; in fact Bmp4 is expressed in the anterior signaling center, while Bmp7 and Follistatin are expressed in a wider domain, along the antero-posterior length of the epithelium. In Dlx5 K/K and DKO embryos Bmp7 is increased throughout the palate, while Follistatin is decreased posteriorly. Furthermore, Dlx5 and Dlx6 are not expressed in the anterior palate, where the Msx1-Bmp4 regulation takes place. Together, these observations suggest that the restoration of palate growth and elevation might result from a recruitment of the central-posterior palate tissue via enhancement of Bmp functions posteriorly.
Bmp signaling and palate morphogenesis
The expression pattern of Bmp2 and K4 is highly reminiscent of that found in other embryonic territories where fusion occurs, such as the frontonasal processes (Gong and Guo, 2003) . Midline fusion of the palatal shelves, thus, is one more example of this important function of Bmp molecules. Bmp4 is also likely to carry out a morphogenetic function in the palatal primordia prior to their fusion, since the palatal shelves of Msx1 K/K mice never come in proximity (Zhang et al., 2002) . Interestingly, in the corresponding region of the palate the Bmp-antagonist Follistatin (Balemans and VanHul, 2002) is only expressed in a restricted dorsal (nasal) domain but not in the signaling center (our data) and might serve the function to restrict the Bmp2 and -4 activity to the tip of the shelves.
The rescue of palatal formation in the DKO can be explained by the increased Bmp7 expression compensating for the reduction of Bmp4 (Fig. 7) . Indeed, disruption of Dlx5 leads to an up-regulation of Bmp7 expression in the palate, also observed in the DKO palate. Bmp7 may serve the dual function of stimulating growth of the palatal mesenchymal cells, a function known for Bmp4 (Zhang et al., 2002) , and that of inducing ossification at later stages (Franceschi et al., 2000) . The possibility that Bmp7 may functionally substitute for other Bmps is supported by the analysis of skeletal phenotypes in compound Bmp mutant mice, showing redundancy in vivo (Zhao, 2002; Goumans and Mummery, 2000; Dudley et al., 1995; Luo et al., 1995; Jena et al., 1997; Solloway and Robertson, 1999) ; in particular Bmp4;Bmp7, but not Bmp2;Bmp7 or Bmp5;Bmp7, double heterozygotes show skeletal abnormalities (Katagiri et al., 1998) , an indication that Bmp4 and Bmp7 might synergistically regulate a common mechanism. At the receptor level, several type I and type II subunits bind (3) (1) Skeletal defects (cartilages and bones) observed at P0. (2) The expression columns combine data from this paper (E13.5 and E14.5) and from published literature. Bmps and induce Smad phosphorylation (Hogan, 1996; Goumans and Mummery, 2000; Zhao, 2002) . Biochemically it is unclear which ligand binds to which receptor complex, and receptor-ligand binding appears to be rather promiscuous. At the transduction level, Bmp4 binds to the Alk3/Alk6 receptors (BMP-R type IA and IB, respectively), while Bmp7 preferentially binds to Alk2 (Aoki et al., 2001) ; however all these receptors induce activation of Smad8 (Kawai et al., 2000) . Thus, in selected biological systems Bmp molecules might be able to compensate each other's activity.
The rescue of palate morphogenesis in the DKO could also be favored by the reduced Follistatin expression observed in the Dlx5 K/K palate (Fig. 7) . Follistatin is a diffusible molecule, whose altered concentration may likely affect adjacent territories, including more anterior palatal domains. The effect should be that of a reduced Bmp antagonist activity in the medial and posterior palatal mesenchyme, where Bmp7 is overexpressed. Functionally, these two effects go in the same direction, since they are expected to potentiate Bmp signaling. The changes in Bmp7 and Follistatin expression in Dlx5 K/K embryos occur at a location in which Dlx5 is not expressed, indicating the cell non-autonomous nature of the palatal rescuing. In the Msx1 K/K palatal shelves Follistatin expression is reduced anteriorly but is maintained posteriorly.
In summary, the effect of the Dlx5 mutation on the Bmp system during palate formation consists in a non-cellautonomous regulation on the expression of Bmp7 and Follistatin with the result of potentiating the Bmp signal. This strengthens the notion that the tight regulation of expression and activity of this class of molecules is essential in the coordination of cellular events leading to growth, morphogenesis and fusion of embryonic structures. More generally, our findings are an illustration of the importance of non-cell-autonomous signaling between adjacent territories, a less well explored level of regulation during embryonic morphogenesis.
Experimental procedures
Targeted disruption of Dlx5 and Msx1
Mice with targeted disruption of Dlx5 have been reported (Acampora et al., 1999) . The targeted allele has the 1st and 2nd exons replaced by the lacZ reporter. The modified null allele, denominated Dlx5 lacZ , allows for detection of the Dlx5-expressing cells by staining for b-galactosidase (b-gal) expression. In all the territories examined b-gal expression recapitulates known Dlx5 expression. Genotypes of the Dlx5 mice were determined as described (Acampora et al., 1999) . Mice with a targeted inactivation of Msx1 have been reported (Houzelstein et al., 1997) . In the targeted allele the nlacZ reporter gene was introduced in phase into the Msx1coding sequence. The modified allele denominated 
Phenotype analysis
Skeletal staining of newborn animals was carried out as previously described (Alizarin and Alcian Blue, Acampora et al., 1999) . Whole-mount detection of b-gal was done on E12.5-E14.5 embryos as described . For histological detection of b-gal, E13.5 and E14.5 embryos was fixed with 4% PAF 20' RT, followed by washes in PBS, sectioning by vibratome (80 mm) and staining as described (Perera et al., 2004) .
In situ hybridization was carried out with DIG-labeled antisense probes for the following genes: Dlx5, a 750 bp fragment spanning the coding sequence; Dlx6, a 350 bp fragment spanning exons 3 and 4 (Perera et al., 2004) ; Msx1, a 550 bp 3 0 spanning the homeodomain; Msx2, containing exon 1; Noggin, obtained from R. Harland (Berkeley, Univ., CA); Nhordin, from Dr J. Belo (Inst Gulbenkian de Cienca, Oeiras, Portugal) and Bmp4, from Dr E. Bober (Martin-Luther Univ., Halle Germany). Probes for murine Bmp7 and Follistatin were obtained by RT-PCR from mouse embryo cDNA and corresponded to, respectively, a 511 bp fragment of the 3 0 UTR and a 534 bp fragment of coding plus 3 0 UTR sequences. With each probe, at least two normal and three mutant specimens were examined. For the palate, frontal 100 mm vibratome sections or 12 mm cryostatic sections from E13.5-E14.5 embryos were obtained serially. Hybridization on vibratome floating slices or on cryostatic sections was performed as described (Perera et al., 2004; Zhadanov et al., 1995) , signal was revealed with BM-Purple (Roche).
RNA quantification by real-time PCR
E14.5 palatal shelves (6 WT and six mutants, two independent experiments) were accurately dissected, pooled in TriPure Reagent (Roche) and extracted as indicated by the manufacturer. As Bmp7 is not expressed in nearby tissues, the only source is the medial palatal mesenchyme. RNA quality, primer efficiency and correct size were tested by RT-PCR and agarose gel electrophoresis. RealTime was performed with LightCycler (Roche) using FastStart DNA MasterPLUS SYBR-Green I (Roche). Five microlitres of cDNA were used in each reactions, standard curve were performed using WT cDNA with four calibration points: 1:10; 1:40; 1:160; 1:640. All samples were in duplicates. Specificity and absence of primer dimers was controlled by denaturation curves. GAPDH was used for normalization, calculated using LightCycler Software 3.5. 
